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Abstract
Background: SIRT1, a NAD-dependent deacetylase, has diverse roles in a variety of organs such as regulation of endocrine
function and metabolism. However, it remains to be addressed how it regulates hormone release there.
Methodology/Principal Findings: Here, we report that SIRT1 is abundantly expressed in pituitary thyrotropes and regulates
thyroid hormone secretion. Manipulation of SIRT1 level revealed that SIRT1 positively regulated the exocytosis of TSH-
containing granules. Using LC/MS-based interactomics, phosphatidylinositol-4-phosphate 5-kinase (PIP5K)c was identified
as a SIRT1 binding partner and deacetylation substrate. SIRT1 deacetylated two specific lysine residues (K265/K268) in
PIP5Kc and enhanced PIP5Kc enzyme activity. SIRT1-mediated TSH secretion was abolished by PIP5Kc knockdown. SIRT1
knockdown decreased the levels of deacetylated PIP5Kc, PI(4,5)P2, and reduced the secretion of TSH from pituitary cells.
These results were also observed in SIRT1-knockout mice.
Conclusions/Significance: Our findings indicated that the control of TSH release by the SIRT1-PIP5Kc pathway is important
for regulating the metabolism of the whole body.
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Introduction
Sir2 (silent information regulator 2) is a NAD
+-dependent
protein deacetylase [1,2]. In yeast, Sir2 mediates transcriptional
silencing at telomeres and regulates the pace of aging [3]. In
C.elegans, one of the Sir2 orthologues, Sir2.1, has been shown to
forestall aging by acting in a DAF-16 signaling pathway [4]. In
mammals, SIRT1, the closest mammalian orthologue of Sir2, has
diverse roles in a variety of organs or tissues [5], and molecular
mechanisms underlying the broad SIRT1 functions are highly
complicated. SIRT1 is shown to be mainly involved in the
regulations of whole body metabolism and physical activity.
SIRT1 promotes free fatty acid mobilization of fat from white
adipose tissues by repressing peroxisome proliferator-activated
receptor-c (PPARc), a nuclear receptor that promotes adipogen-
esis [6]. SIRT1 also regulates the gluconeogenic and glycolytic
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deacetylating PGC-1a, a key transcriptional regulator of glucose
production [6]. SIRT1 plays other roles in stabilizing genomic
DNA and proteins [7,8].
Recently, evidence has accumulated that SIRT1 could be
involved in the endocrine system. In pancreas, SIRT1 modulates
serum glucose levels by regulating pancreatic insulin through
repressing the expression of mitochondrial uncoupling protein 2
(UCP2) [9]. In agreement with these findings, SIRT1 knockout
(KO) mice show impaired glucose-stimulated insulin secretion
[10]. Neuron-specific SIRT1 KO mice display reduced growth
hormone level, which results in the impairment of body growth
[11]. SIRT1 transgenic mice have reduced levels of blood
cholesterol and adipokines, and are more metabolically active
than littermate controls [12]. SIRT1 is expressed in the
anorexigenic proopiomelanocortin (POMC) neurons [13], and
hypothalamic SIRT1 mediates the up-regulation of the S6K
pathway [14]. Despite the accumulation of evidence for the
importance of SIRT1 in endocrine system, highly basic questions
have remained to be addressed such as whether SIRT1 regulates
metabolism in the brain and pituitary gland.
Hormones and neurotransmitters are transported as secretory
granules by diverse cellular processes. Long-distance transport of
these vesicles is regulated by kinesin-driven transport [15,16] and
posttranslational modifications, such as tyrosination [17] and
polyglutamylation [18]. When the vesicles come to the terminal
points, the process is passed to the exocytotic mechanisms
[19,20,21]. Phosphatidylinositol plays critical roles in this
exocytotic step [22]. The phosphatidylinositol-4,5-bisphosphate
(PI(4,5)P2) interacts with the some proteins involved in the
exocytotic machinery, such as the Ca
2+-dependent activator
protein for secretion (CAPS) which is a priming factor, and
synaptotagmin which is a Ca
2+ sensor [23]. How SIRT1 is
involved in the exocytosis machineries is poorly understood.
In the present study, we investigated how SIRT1 regulates
hormone release. We identify the SIRT1 substrate, and provide
evidence for a regulatory mechanism of SIRT1- and SIRT1
target-dependent hormone release.
Results
Abundant expression of SIRT1 in pituitary thyrotropes
In previous work, SIRT1 KO shows the decrease in the
plasma level of thyroid hormone [24]. The report suggests that
SIRT1 is involved in the regulatory axis of thyroid activity or
function. We thus first investigated where SIRT1 was predom-
inantly expressed in the whole body. To this end, we performed
Western blot analyses with a commercially available anti-SIRT1
antibody on lysates obtained from a variety of adult murine
tissues. These assays revealed that the expression level of the
SIRT1 protein in the pituitary glands was highest among that in
many other adult murine tissues (Fig. 1A). The SIRT1
expression in other tissues was detected as previous reported
when the expose time was elongated (data not shown). The
SIRT1 expression in the pituitary gland was also highest when
compared to that in other brain tissues (Fig. 1B). We next
performed immunohistochemical analysis of sagittal slices of rat
brain. The immunohistochemical analysis revealed strong
expression of SIRT1 in the anterior pituitary (Fig. 1C). We
tested the specificity of the antibody used in Fig. 1A–C by
performing Western blotting with SIRT1 KO pituitary sample as
a negative control (Fig. 1D). As SIRT1 signal was not detected in
the SIRT1 KO tissue sample using the antibody, the antibody
has an excellent specificity (Fig. 1D).
Pituitary gland is a critical component of the endocrine system
that is present in all vertebrates, and pituitary hormones control
homeostasis of the whole body [25]. The anterior pituitary secretes
thyroid-stimulating hormone (TSH), follicle-stimulating hormone
(FSH), luteinizing hormone (LH), adrenocorticotropic hormone
(ACTH), growth hormone (GH), and prolactin (PRL). We used
immunohistochemistry to examine the distribution of SIRT1
among hormone-secreting pituitary cells in mice and humans.
SIRT1 was most frequently localized in TSH-positive cells, but
barely observable in ACTH-, FSH-, LH-, GH-, and PRL-positive
cells in mice (Fig. 1E) and humans (Fig. 1F). We examined human
pituitary glands that were obtained during the autopsies of 20
cadavers, ranging in age from 20 to 103 years. SIRT1-positive
cells were mostly found to be localized in TSH-positive cells in the
case of all the cadavers (data not shown). These results show that
mammalian SIRT1 is highly abundant in thyrotropes. Although
normally a nuclear protein, the SIRT1 protein was in the
cytoplasm of thyrotropes (Fig. 1E and 1F), a distribution similar to
that reported for alpha cells of the pancreatic islets, another type of
endocrine cells [9].
SIRT1-mediated positive regulation of TSH secretion
We next examined whether SIRT1 regulates TSH secretion by
manipulating SIRT1 expression level in pituitary cells. SIRT1-
expression plasmids or SIRT1-RNAi was introduced by electro-
poration into primary cultures of rat anterior pituitary. The
cultured cells expressed either increased (overexpression) or
decreased (knockdown) levels of SIRT1 protein compared to the
controls (Fig. 2A). SIRT1 overexpression and knockdown led to an
increase and decrease, respectively, in the amount of TSH
secreted into the medium (Fig. 2B).
To test the effect of SIRT1 on the release of secretory granules,
we used rat pituitary cells transfected with an expression vector
encoding enhanced green fluorescent protein (EGFP) fused in
frame with TSHb. TSH is a 28k-Da heterodimer composed of
covalently linked a and b subunits. The a subunit is common to
TSH, FSH, and LH, whereas the b subunit is specific to the TSH
molecule [26]. We observed, in real-time, the motion of individual
EGFP-TSHb granules undergoing exocytosis in living cells by
using total internal reflection fluorescence (TIRF) microscopy—a
method that enables fluorescence excitation within a closely
restricted domain situated close to the plasma membrane [21,27].
Given the characteristic of TIRF microscopy, the granule
disappearance represents exocytosis of EGFP-TSHb or returning
of vesicles to cytoplasm via kiss-and-run recycling system. Thus the
disappearance of granules is a result of vesicle trafficking. We
recorded sequential images every 5 s (Video S1–S3) and counted
the number of EGFP-positive granules that disappeared during the
5 s intervals (surrounded by red circles in Fig. 2C). The number of
vanishing granules was increased in the SIRT1-overexpressing
cells, and conversely decreased in the SIRT1-RNAi knockdown
cells compared to the control cells (Fig. 2D). Hence, the trafficking
of TSH-containing vesicles was more active in the SIRT1-
overexpressing cells, and lesser in SIRT1-RNAi knockdown cells,
compared to the control cells. These findings show that SIRT1
activates TSH release in thyrotropes.
Identification of PIP5Kc as a SIRT1-binding protein
To determine the molecular mechanisms that regulate TSH
release by SIRT1, we sought out the potential targets that could
physically associate with SIRT1. It is known that the catalytically
inactive form of protein kinase binds more avidly to its substrates
than the native form of enzyme, so substrates are more effectively
pulled down with the mutant enzyme compared with the wild-type
SIRT1 Regulates TSH Release
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of SIRT1 [29,30], to screen for binding partners. The Flag-tagged
SIRT1 and SIRT1 (H355A) constructs were expressed in
HEK293T cells and immunoprecipitated with an anti-Flag
antibody. The immunoprecipitates were digested and then
subjected to a nanoscale liquid chromatography-tandem mass
spectrometry (LC-MS/MS) system [31]. Proteins identified as
candidates of SIRT1 binding partners included phosphatidylino-
sitol-4-phosphate 5-kinase (PIP5Ks) (Fig. 3A). The enzymes
PIP5Ks (PIP5Ka, PIP5Kb, and PIP5Kc) are enzymes that
catalyze the synthesis of PI(4,5)P2 mainly through the cellular
route [32]. We focused on PIP5Ks since PIP5Kc is reported to
play an important role in the exocytosis of large dense-core vesicles
by inducing the synthesis of PI(4,5)P2 in endocrine cells [33].
The common regions of all PIP5Ks were pulled down with
SIRT1 inthe fist screeningwith LC-MS/MS.To examine ifSIRT1
more specially interacts with PIP5Kc than with the other PIP5Ks,
we performed immunoprecipitation analysis against endogenous
proteins with antibodies to SIRT1 and to PIP5Ks. Amongst the
PIP5Ks examined, PIP5Kc was selectively immunoprecipitated
withSIRT1 (Fig. 3B). Further investigation with deletion mutants of
PIP5Kc revealed that the interaction between SIRT1 and PIP5Kc
was mediated through a region of the kinase core domain [34]
(amino acid residues 247—281) of PIP5Kc (Fig. 3C).
SIRT1-mediated deacetylation of PIP5Kc
The binding of SIRT1 with PIP5Kc suggests that SIRT1
deacetylates acetylated PIP5Kc. Treatment with nicotinamide
Figure 1. Effect of SIRT1 on hormone secretion. (A, B) Western blot analysis of SIRT1 in the systemic organs (A) and nerve tissues (B) of mice. (C)
Immunohistochemical staining of SIRT1 in the rat brain. The upper right panel shows the anterior pituitary area at higher magnification. Scale bar,
1 cm. (D) SIRT1 immunoreactivity is absent in the pituitary gland of SIRT1 KO mouse. (E, F) Double immunostaining with SIRT1 (red) and pituitary
hormones (green) in the pituitary gland of a 12-weeks old mouse (E) and a 64-years old human (F). Scale bar, 100 mm.
doi:10.1371/journal.pone.0011755.g001
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PIP5Kc, but did not alter the acetylation levels of PIP5Ka and
PIP5Kb (Fig. 4A).
The SIRT1-binding site of PIP5Kc has 2 lysine residues
(residues 265 and 268; shaded in Fig. 4B) besides the 5 identical
lysine residues conserved in all the 3 PIP5Ks (residues 255, 260,
266, 270 and 276) (Fig. 4B) [34]. Within light of the preferential
interaction between SIRT1 and PIP5Kc, we hypothesized that
SIRT1 mainly deacetylates lysines 265 and/or 268 of PIP5Kc.T o
test this hypothesis, we constructed a PIP5Kc plasmid in which 2
lysine residues were substituted with arginine residues (K265/
268R). As expected, the K265/268R mutant was not further
acetylated, regardless of treatment with NAM (Fig. 4C). This
indicates that SIRT1 deacetylates the residues 265 and/or 268 of
PIP5Kc. To prove that SIRT1 directly deacetylates PIP5Kc,w e
performed an in vitro deacetylase activity assay. PIP5Kc deacetyla-
tion occurred upon the addition of recombinant wild-type SIRT1
but not the inactive form of SIRT1 (H355A) (Fig. 4D). In contrast,
PIP5Ka and PIP5Kb were not deacetylated by SIRT1 (Fig. 4D).
Taken together, our findings indicate that SIRT1 selectively
deacetylates PIP5Kc among all the PIP5Ks.
We next asked whether the acetylation state affects the
enzymatic activity of PIP5Kc. We measured the in vitro kinase
activity of PIP5Kc with some modifications of the assay system of
previous reports [36,37]. We preincubated PIP5Kc with recom-
binant wild-type SIRT1 or the inactive form of SIRT1 (H355A)
for 3 h at 30uC, and then examined the activity of PIP5Kc. The
production of PIP2 was significantly increased when PIP5Kc was
deacetylated with wild-type SIRT1, whereas no increase occured
when PIP5Kc was incubated with the inactive SIRT1 (H355A)
(Fig. 4E). These results indicate that SIRT1 deacetylates PIP5Kc,
thereby increasing the latter’s activity. Consistent with this, PIP2
production was significantly decreased in HEK293T cells treated
with SIRT1-RNAi (Fig. 4F and 4G). Our findings demonstrate
that SIRT1 increases the kinase activity of PIP5Kc by deacetylat-
ing this kinase.
Involvement of PIP5Kc in SIRT1-mediated TSH Secretion
PIP5Kc is the major PI(4,5)P2 synthesizing enzyme in the brain
[38]. In addition, PIP5Kc KO mice show defects in vesicle
trafficking [33]. We examined whether PIP5Kc was expressed and
physically interacted with SIRT1 in the pituitary gland, before
testing whether PIP5Kc is involved in the SIRT1-mediated TSH
secretion in pituitary cells. PIP5Kc is expressed in pituitary gland
in addition to other regions of the mouse brain (Fig. 5A). In the
pituitary gland, SIRT1 and PIP5Kc were detected in the cytosolic
fraction (Fig. 5B). Further, they colocalized in the cytoplasm of
many cells in the anterior pituitary gland (Fig. 5C). These two
proteins were coimmunoprecipitated with each other from
pituitary cytosolic lysates by antibodies specific for each protein
(Fig. 5D). Thus, SIRT1 and PIP5Kc are physically associated in
pituitary cells.
To determine whether PIP5Kc is involved in SIRT1-mediated
TSH secretion in pituitary cells, we knocked down PIP5Kc in
Figure 2. SIRT1 upregulates exocytosis of TSH. (A) Western blot analysis of SIRT1 in primary pituitary cells and in cells overexpressing (O/E)
SIRT1 (left panel) and SIRT1 RNAi cells (right panel) levels. (B) Amounts of TSH secreted by SIRT1-O/E and SIRT1-RNAi pituitary cells over 24h (n=10).
Statistical analyses were performed using Fisher’s PLSD test. *P,0.05 versus control. (C) A TIRF image of an anterior pituitary cell. Several GFP-TSH
granules that disappeared within 5 s are circled in red. Scale bar, 20 mm. (D) Number of expelled TSH granules were morphologically identified using
the TIRF images (n=5). Statistical analyses were performed using Fisher’s PLSD test. *P,0.05 versus control. Values represent mean6SEM (% of
control: B and D).
doi:10.1371/journal.pone.0011755.g002
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against PIP5Ks were examined; RNAi against each PIP5K
showed the specific knockdown effect to each target (Fig. 5E).
We confirmed that PIP2 production was significantly decreased in
the PIP5K-RNAi knockdown pituitary cells (Fig. 5F). Basal-level
TSH secretion was reduced by the knockdown of PIP5Kc,
whereas neither PIP5Ka-RNAi nor PIP5Kb-RNAi knockdown
showed such an effect (Fig. 5G). Strikingly, the knockdown of
PIP5Kc completely abolished the effect of SIRT1 overexpression
on the enhancement of TSH secretion (Fig. 5H). This result
demonstrates that SIRT1 and PIP5Kc work in the same pathway,
and supports our concept that SIRT1 regulates TSH secretion via
the deacetylation of PIP5Kc.
SIRT1 KO mice show high acetylated-PIP5Kc, low PIP2
and low TSH Secretion
To confirm that SIRT1 regulates TSH secretion in vivo via
modulating PIP5Kc acetylation level and its lipid kinase activity,
we investigated SIRT1 KO mice. First, we examined the level of
acetylated PIP5Kc in the pituitary gland of SIRT1 KO mice. The
level of acetylated PIP5Kc was higher in SIRT1 KO mice than
that in wild-type (WT) mice (Fig. 6A). The PIP2 levels in the brain
were lower in the SIRT1 KO mice than in the WT mice (Fig. 6B).
SIRT1 KO mice have smaller pituitary than wild-type mice
[39]. Thus, we examined the number of TSHb cells in SIRT1 KO
mice, before investigating the TSH release. Unexpectedly, the
number of TSHb cells was higher in the pituitary glands of SIRT1
KO when compared to normal (Fig. 6C). Consistent with this
finding, the total TSH protein content in SIRT1 KO pituitary was
significantly elevated (Fig. 6D). Despite the increased pituitary
TSH contents, the amount of secreted TSH from SIRT1 KO
pituitary glands was significantly lower than that from WT
pituitary glands (Fig. 6E). The difference was more remarkable
when the plasma TSH level was normalized with the number of
pituitary TSHb cells (Fig. 6F). There was no difference in the TSH
mRNA levels in the thyrotropes of SIRT1 KO and WT mice
(Fig. 6G). Taken together, these findings support our model that
SIRT1 regulates TSH release through modulating PIP5Kc
activity (Fig. 7).
Discussion
In the present study, we showed that SIRT1 is abundantly
expressed in TSH-producing cells in the anterior pituitary gland.
Hypothalamic–pituitary–thyroid (HPT) axis regulates energy
expenditure, oxygen consumption, and fuel metabolism [40].
Thyroid hormones (triiodothyronine [T3] and thyroxine [T4])
negatively regulate the HPT axis [41,42], and influence adipose
tissue metabolism and cholesterol homeostasis [43]. In addition,
the combination of serum TSH and tissue insulin sensitivity has
important effects on serum lipid parameters in type 2 diabetes
[44]. SIRT1 is also involved in insulin sensitivity and lipid
metabolism [5]. Under fasting conditions, SIRT1 has a negative
effect on insulin sensitivity [45]. Under fed conditions, activation
of SIRT1 improves insulin sensitivity [46,47]. Thus it is reasonable
to speculate that the SIRT1-PIP5Kc pathway described in this
study represents a key event in the process of energy metabolism.
The longevity response to calorie restriction (CR) is actively
regulated by nutrient-sensing pathways involving the kinase target
of rapamycin (TOR) [48], AMP kinase [49,50] and insulin/
insulin-like growth factor (IGF-1) signalling [51] in lower
organisms and mice. Sirtuins is also thought to be linked to CR
Figure 3. Identification of PIP5Kc as a SIRT1-binding protein. (A) PIP5Ks were identified as SIRT1-associated protein by immunoprecipitation
with anti-FLAG antibodies from HEK293T cells expressing FLAG-SIRT1. A full-length SIRT1 and inactive form of SIRT1 (H355A) interacted with PIP5K
(+). (B) Immunoprecipitation analysis of endogenous SIRT1 and endogenous PIP5Ka, PIP5Kb, PIP5Kc, or PIP4Kb in HEK293T cells. (C) Mapping the
interaction interface of SIRT1 with PIP5Kc. A schematic representation of the SIRT1 interaction site (right panel; positive (+), negative (2)).
doi:10.1371/journal.pone.0011755.g003
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Resveratrol, an activator of sirtuins, antagonizes the mTOR/S6K
pathway [53]. In addition, sirtuins and TOR have opposing effects
on autophagy independently from each other. Thus sirutins and
the downstream signalling pathway form a complex network. It
will be important to study to address whether SIRT1 in the
pituitary also controls the other endocrine axes and other
downstream target involving aging and lifespan.
In thyrotropes, SIRT1 was found to be distributed in the
cytosol, suggesting a role of SIRT1 in the cytoplasm (Fig. 5B). In
fact, we confirmed the colocalization and binding between
PIP5Kc and SIRT1 in the pituitary gland (Fig. 5C). SIRT1 has
been shown to shuttle between the cytoplasm and nucleus [54].
SIRT1 is localized in cytoplasm of pancreatic a cells and
endothelial cells, and localized in nuclei in liver, muscle, and
white adipose tissue [9,55]. Consistent with our findings that
SIRT1 and PIP5Kc were localized in the cytoplasm of pituitary
gland cells, SIRT1 and endothelial nitric oxide synthase (eNOS)
also colocalize and coprecipitate in cytoplasm of endothelial cells
[55]. SIRT1 deacetylates eNOS for stimulating the activity and
increases endothelial nitric oxide (NO) [55]. This result suggests
SIRT1 has some targets in the cytoplasm as well as in the nucleus.
Our findings indicate that SIRT1 deacetylates acetylated
PIP5Kc at K265/K268, thereby activating TSH secretion from
the pituitary gland (Fig. 7). The deacetylated form of PIP5Kc is
more enzymatically active and the PIP2 synthesized the secretion
Figure 4. Activation of PIP5Kc by deacetylation. (A, C) Effects of NAM on the acetylation of PIP5Ks (A) and PIP5Kc K265/268R (C). The level of
acetylated-lysine/PIP5K level was determined. Statistical analyses were performed using Student’s t test (n=3). *P,0.05 versus the non-NAM-treated
group. (B) Sequence alignment of PIP5Ks. PIP5Ka (amino acids 205–226), PIP5Kb (246–267), and PIP5Kc (255–276) are shown. The light blue columns
indicate candidates for deacetylation site by SIRT1. (D) In vitro deacetylation of PIP5Ks by SIRT1. Each Flag-PIP5Ks were purified from HEK293T cells
after treatment with 5 mM NAM and was incubated with full-length recombinant SIRT1 or SIRT1 (H355A) in the presence of NAD
+ for 3 h at 30uC. The
acetylated-lysine/PIP5K level was determined. Statistical analyses were performed using Fisher’s PLSD test or Student’s t test (n=3). *P,0.05 versus
control. (E) TLC analysis of [
32P]PI(4,5)P2 produced by acetylated PIP5Kc incubated with recombinant SIRT1 or SIRT1 (H355A). The PI(4,5)P2 level was
measured using the ImageJ software (n=3). Statistical analyses were performed using Fisher’s PLSD test. *P,0.05 versus control. (F) Western blot
analysis of SIRT1 in HEK293 cells and SIRT1 RNAi cells. Actin was used as the control. (G) TLC analysis of [
32P]PIP2 that was extracted from SIRT1 KD
HEK 293T cells metabolically labelled (for 24 h) with [
32P]orthophosphate. The PIP2 level was corrected for the PC level (n=5). PC,
phosphatidylcholine; SM, sphingomyelin; PS, phosphatidylserine; PA, phosphatidic acid; PI, phosphatidylinositol; and PIP, phosphatidylinositol
phosphate. Values represent mean6SEM (A–D and F).
doi:10.1371/journal.pone.0011755.g004
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correspond to R215 and R218 of PIP5Kb in human, respectively.
The region from Y209 to R215 in PIP5Kb is a phosphatidic acid
(PA)-binding site, and the kinase activity of PIP5Kb is completely
lost when basic residues in this site are substituted with acidic
residues [56]. This loss of function is thought to be caused by the
alteration of the electrostatic interactions in the pocket composed
of the PA-binding site and the surrounding residues. Since
acetylation of lysine residues causes the alteration of electrical
charge, the acetylation-deacetylation cycle we describe can easily
be understood to regulate the kinase activity of PIP5Kc. Although
our work points to SIRT1 as the deacetylase responsible for
activating PIP5Kc, we have no information of which protein
acetyltransferase is involved in the inactivating (acetylation)
reaction.
We also visualized the vesicle of EGFP-TSHb on exocytosis in
primary culture of pituitary cells by using TIRF microscopy.
Because the TIRF microscope only visualizes vesicles just beneath
the membrane, the traffic event is mainly reflecting exocytosis
[27,57,58]. The number of disappeared TSH-containing granules
within 5 s was increased in the SIRT1-overexpressing cells
compared to the control cells (Fig. 2C and 2D), confirming the
activation of vesicle trafficking. In accordance with our findings,
previous work has shown that the absence of PIP5Kc causes a
reduction of the readily releasable vesicle pool and a delay of
fusion pore expansion indicating a defect in vesicle priming in
chromaffin cells [33]. Our assay system revealed that PIP5Kc
knockdown inhibited PIP2 production and TSH secretion (Fig. 5G
and 5H). Produced PI(4,5)P2 produced by PIP5Kc is an important
regulator of synaptic vesicle trafficking in nerve terminal [59].
Although SIRT1 has a many substrates, the SIRT1-PIP5Kc
pathway is important for intracellular trafficking and secretion in
the thyrotropes. We also visualized the vesicle of EGFP-growth
hormone (GH) on exocytosis in GH3 pituitary cells by using as
TIRF microscopy (data not shown). Consistent with the
observation of TSH-containing granules trafficking, the numbers
of disappearing GH-containing granules was increased in the
SIRT1-overexpressing cells (data not shown). These findings
showed that the SIRT1-PIP5Kc secretion pathway is shared by
thyrotropes and other pituitary endocrine cells.
The physiological properties of the SIRT1 KO mouse are also
consistent with the model proposed here. The levels of PIP5Kc
acetylation were elevated in SIRT1 KO mice and the TSH
secretion levels were lower (Fig. 6D). SIRT1 KO mice have
smaller pituitary than wild-type mice, however differentiation of
the anterior pituitary occurs normally [39]. GH levels and insulin-
like growth factor (IGF)-1 are not affected in SIRT1 KO mice
[39]. In neuron-specific SIRT1 KO mice, the production and
Figure 5. SIRT1 regulates TSH secretion via PIP5Kc (K265/K268). (A) Western blot analysis of PIP5Kc in the nerve tissues of mice. (B)
Distribution of SIRT1 and PIP5Kc in fractionated pituitary gland of mice. SIRT1 and PIP5Kc were found to be present in cytosolic fractions rather than
nuclear fractions. The first lane contains crude extract prior to separation. Nucleoporin, a nuclear marker; actin, a cytosolic fraction marker. (C) Double
immunostaining with SIRT1 (red) and PIP5Kc (green) in the anterior pituitary gland of rats. Scale bar, 10 mm. (D) Co-immunoprecipitation analysis of
SIRT1 and PIP5Kc in the cytosolic fraction of the pituitary gland of mice. Rabbit IgG was used as the negative control. (E) Western blot analysis of each
PIP5K in PIP5Ks RNAi knockdown cells. (F) TLC analysis of [
32P]PIP2 was extracted from PIP5Kc RNAi pituitary cells metabolically labelled (for 24 h) with
[
32P]orthophosphate. The PIP2 level was corrected for the PC level (n=5). (G) Amounts of TSH secreted in each PIP5Ks RNAi knockdown cells (n=16).
(H) Amounts of TSH secreted in cells overexpressing SIRT1 and PIP5Kc RNAi (n=16). Empty vectors and random RNAi constructs were used as
controls. Statistical analyses were performed using Fisher’s PLSD test. *P,0.05 versus control. Values represent mean6SEM (% of control: F–H).
doi:10.1371/journal.pone.0011755.g005
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The production of all pituitary hormones is regulated at least in
part by signals from the hypothalamus. TSH-releasing hormone
(TRH) secreted by the hypothalamus is the main stimulator of
TSH synthesis and secretion [60,61]. It is generally considered
that low serum TSH levels are attributable to the inhibition of
TSH synthesis in the pituitary, which depletes the existing reserves
of the hormone (exhausting the TSH ‘‘stock’’), without changing
the rate of secretion (‘‘flow’’). However, in this study, SIRT1
regulates release (related to ‘‘flow’’, not ‘‘stock’’) of TSH,
suggesting that the physiological regulation of the pituitary-thyroid
axis is dependent on regulated secretion.
The activity of SIRT1 is thought to be modulated by the
nutritional status of the cell [62]. Recently, the expression of
SIRT1 regulates oncogenic viral protein HPV7 [63] and locally
acting IGF-1 isoform (mIGF-1), not circulating IGF-1 isoform
[64]. Thus the activity and expression of SIRT1 changes topically
and temporally. The core circadian rhythm regulator protein
circadian locomotor output cycles kaput (CLOCK) is a histone
acetyltransferase, and its activity is counterbalanced by NAD
+ and
SIRT1 [65]. The circadian rhythm modulates metabolic activities
on a long-term basis, while intracellular traffic regulation of TSH
by SIRT1 might provide short-term control of metabolism
dependent on nutrient availability.
Materials and Methods
Study subjects
SIRT1 KO mice were generated on a CD1 and 129/J mixed
genetic background, and genotyped using a polymerase chain
Figure 6. High Ac-PIP5Kc, low PIP2, and low TSH secretion in pituitary glands obtained from SIRT1 KO mice. (A) Levels of acetylated
PIP5Kc in the pituitary of SIRT1 KO mice and WT mice. Endogenous PIP5Kc was immunoprecipitated. The acetylated-lysine/PIP5Kc level was
measured (n=3). (B) TLC analysis of PIP2 levels in the brain of SIRT1 KO mice and WT mice (WT: n=6, KO: n=6). (C) The number of TSHb-
immunopositive cells in SIRT1 KO mice and WT mice (n=5). (D) Pituitary concentrations of TSH in SIRT1 KO mice and WT mice (n=10). (E) Levels of
TSH secreted by the pituitary cells in the organ culture over 24 h in SIRT1 KO mice and WT mice (n=7). (F) Plasma TSH levels per TSH-
immnunopositive cell in SIRT1 KO mice and WT mice (n=5). (G) mRNA levels of anterior pituitary hormone in SIRT1 KO mice and WT mice. RNA levels
were determined using RT-PCR analysis. GAPDH was used as a loading control (n=3). Values represent mean6SEM. Statistical analyses were
performed using Student’s t test or Mann-Whitney U test. *P,0.05 versus WT.
doi:10.1371/journal.pone.0011755.g006
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ad libitum for both groups. Human tissue sections were obtained
from the Tokyo Medical and Dental University, and Tokyo
Metropolitan Institute of Gerontology. These experiments were
approved by the Mitsubishi Kagaku Institute of Life Science Ethics
Committee. All experiments were reformed according to protocols
approved by the Animal Care and Use Committee of Mitsubishi
Kagaku Institute of Life Sciences.
Antibodies
We used the following antibodies: anti-SIRT1, b-actin, and
Flag-M2 (Sigma-Aldrich); PIP5Kc and nucleoporin (BD Trans-
duction Laboratories); acetylated lysine (BioVision); GFP and
agarose-conjugated GFP (Medical & Biological Laboratories);
GAPDH (Millipore, Bedford, MA); ACTH (Nichirei), FSH and
GH (DakoCytomation); TOTO-3 (Invitrogen). The anti-TSH,
anti-LH, and anti-PRL antibodies were gifted by the Biosignal
Research Center, Institute for Molecular and Cellular Regulation,
Gunma University. For immunoprecipitation, Kanaho’s lab
prepared polyclonal antibodies against mouse PIP5Ka, PIP5Kb,
and PIP5Kc [37]. PIP4Kb, prepared in Moses V. Chao’s lab, was
detected by using a polyclonal antibody [67]. Secondary
antibodies were obtained from Jackson Immunoresearch and
Molecular Probes.
Protein identification by LC-MS/MS analysis
Flag-SIRT1-associated complexes were digested with Achromo-
bacter protease I, and the resulting peptides were analyzed using a
nanoscale LC-MS/MS system. The criteria for match acceptance
have been reported previously [31].
Plasmids and transfection
Plasmids encoding Flag-tagged SIRT1 were constructed using
the pCMV-Tag2 or pCMV-Tag4 vectors (Stratagene). SIRT1
(H355A) was generated by mutating histidine 355 to alanine
[29,30]. Plasmids encoding GFP-PIP5Ks or N-terminally epitope
Flag-tagged PIP5Ks were constructed using the pcDNA3-GFP or
pcDNA3-Flag (Invitrogen) vectors, as described previously [36].
The QuickChange Site-Directed Mutagenesis (Stratagene) kit was
used to generate the PIP5Kc (K265/268R) mutants. HEK293T
cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal calf serum. SIRT1 and
PIP5K stealth RNAi were purchased from Invitrogen, and
transfections were performed using Lipofectamine 2000 (Invitro-
gen) in accordance with the manufacturer’s instructions. Rat
TSHb cDNA was generated by PCR. The PCR product was
inserted into TagGFP (Evrogen). All constructs were confirmed by
sequencing. The expression of TSHb was confirmed by ELISA
(Shibayagi), using lysates of GFP-TSHb-overexpressing cells.
Immunoprecipitation
The transfected HEK293T cells (6-cm dish) were lysed in lysis
buffer (25 mM Tris-HCl [pH 8.0], 100 mM NaCl, 2 mM
ethylenediamine acetic acid (EDTA) and 0.2% Triton X-100)
containing protease inhibitors, 0.5 mM trichostatin A, and 5 mM
NAM. After brief sonication, the lysates were cleared by
centrifugation. The immunoprecipitates thus obtained were
analyzed by immunoblotting. Cytoplasmic proteins obtained from
rat pituitary were prepared using NE-PER Nuclear and
Cytoplasmic Extraction Reagents, according to the manufacturer’s
instructions (Pierce).
Western blot analysis
Lysate proteins were separated on an 8% SDS-PAGE gel and
then blotted onto polyvinylidene difluoride membranes (Milli-
pore). The membranes were blocked using Block Ace (Dainippon
Seiyaku) and probed with the appropriate primary antibodies. The
bound primary antibodies were detected using the corresponding
horseradish peroxidase-conjugated secondary antibodies. The
signal was visualized using the ECL kit (GE Healthcare Bio-
Figure 7. Model for the potential roles of SIRT1 in TSH secretion. Proposed model for regulation of TSH secretion by SIRT1.
doi:10.1371/journal.pone.0011755.g007
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software.
Primary pituitary culture, electroporation and hormone
assay
Pituitary cell cultures were prepared from the anterior pituitary
glands of 12- to 15-week-old male Wistar-Imamichi rats. The
pituitary glands were finely minced and then digested by rapid
agitation in DMEM containing 4 mg/mL collagenase (type 2;
Worthington), 2 mM L-glutamine, 25 mM HEPES, and 400 mg/
mL DNase for 30 min at 37uC [68]. The pituitary cells were
transfected using a microporator (Digital Bio Technology). In all,
1.5610
5 cells were electroporated with DNA (0.5 mg) or RNA
(100 nM) at 1,500 V and a pulse width of 30 ms and seeded in 24-
well plates (hormone assay) or 35-mm dishes (TIRF analysis). The
cells were incubated in high-glucose DMEM containing 5% FBS
and 15% horse serum at 37uC under 5% CO2. At 2 days after
electroporation, the pituitary cells were preincubated in a buffer
containing low amounts of K
+ (140 mM NaCl, 4.7 mM KCl,
2.5 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4,2 0 m M
HEPES [pH 7.4] and 11 mM glucose) for 30 min, and then
incubated in the same buffer for 24 h at 37uC. The levels of the
hormones released into the culture medium were measured using
radioimmunoassay kits for rat TSH (Shibayagi). The cells were
harvested using celLytic buffer M (Sigma-Aldrich) containing
protease inhibitors (Complete EDTA free; Roche Diagnostics).
After removal of the cellular debris, the protein concentrations in
the lysates were determined using the Bradford method. The
pituitary cells were observed by TIRF confocal microscopy 1 day
after electroporation. The plasma concentrations of mouse TSH
were measured using radioimmunoassay kits (National Institute of
Diabetes and Digestive and Kidney Diseases).
TIRF microscopy
For TIRF microscopy, a total internal reflection system (Nikon)
was used with minor modifications. Light from an Ar laser (488 nm)
was introduced into an inverted epifluorescence microscope
through a single-mode fiber and a double-illumination lens. The
cells were observed in the thermostat-controlled stage (37uC).
PIP5K acetylation assay and in Vitro deacetylation assay
HEK293T cells were transfected with Flag-PIP5Kc, Flag-
PIP5Kc (K265/268R), Flag-PIP5Ka, or Flag-PIP5Kb and treated
with 0 mM or 5 mM NAM (Sigma-Aldrich). After 24 h, the cells
were placed in celLytic buffer M and immunoprecipitated. The
Flag-PIP5Ks were eluted using the Flag peptide. The eluted Flag-
PIP5Ks were combined with either recombinant SIRT1 or SIRT1
(H355A) in a reaction buffer (50 mM Tris-HCl [pH 8.8], 4 mM
MgCl2 and 0.5 mM DTT), 100 mM of NAD
+ was added, and the
complexes were incubated for 3 h at 30uC as described [30]. The
reaction mixture was used for measuring the PIP5Kc activity.
Measurement of PIP5Kc activity
The PIP5Kc activity was determined according to the
procedure described in a previously reported [36]. Briefly,
0.1 pmol of PIP5Kc was incubated at 37uC for 25 min in
50 mL of 50 mM Tris–HCl, (pH 7.5), 1 mM EGTA, 10 mM
MgCl2 and 0.004% (w/v) NP-40 containing 50 mM PI(4)P and
50 mM [c-
32P]ATP (0.1 mCi/assay). After extraction using the
Bligh and Dyer method, the lipids were separated by thin-layer
chromatography (TLC) as previously reported [36]. The
[
32P]PI(4,5)P2 produced was analyzed with an FLA2000 Bio-
imaging analyzer (Fuji Photo Film).
Lipid biochemistry
The HEK293T cells or pituitary cells were spread on a 6-cm
dish at concentrations of 5610
5 cells/well and the plates were
incubated for 24 h. These cells were transfected or electroporated
with SIRT1 stealth RNAi incubated with 4mCi of [
32P]ortho-
phosphate in phosphate-free DMEM. After 48 h of incubation,
the lipids were extracted using chloroform:methanol:1N HCl
(3:3:1, v/v). The lipids were dissolved in chloroform:methanol (2:1)
before being spotted onto a TLC plate (silica gel 60; Merck). The
plate had been sprayed with potassium oxalate, using a solvent
system comprising 1.0% potassium oxalate in methanol:water (2:3,
v/v), and pre-activated by heating at 110uC for 60 min before the
spotting. The chromatogram was developed in chloroform:metha-
nol:20% methylamine (60:36:10, v/v/v). The radioactivity was
visualized using a Fuji FLA2000 bioimaging analyzer. Lipids were
extracted from the mouse brain, corrected for tissue weight, and
TLC was performed as described above. Each spot was visualized
using 0.005% primuline, a fluorescent dye. The signals were
quantified using ImageJ imaging software.
Immunohistochemistry
The isolated mouse and rat organs and the cultured cells were
fixed with 4% paraformaldehyde and processed for immunostain-
ing as described previously [69,70]. Human pituitary glands were
obtained by concluding autopsies on the bodies of 20 individuals
aged 20—103 years at the time of death. None of these individuals
had a clinical history of abnormal endocrine dysfunction. Half of
each pituitary gland was serially sectioned and the sections were
scanned at a magnification of 40X. The total number of cells and
the number of TSH-immunopositive cells in the entire area in
each field-of-view were counted [71].
RT-PCR
TotalRNA wasextracted using Sepasol reagent (Nakalai Tesque),
precipitated by ethanol in the presence of ethachinmate (Nippon
Gene), and reverse transcribed using ReverTraAce(TOYOBO).We
used the following primers: 59-CGTCCCGTAGACAAAATGGT-
39 and 59-GAATTTGCCGTGAGTGGAGT-39 for mouse GAP-
DH, 59-CGCATACGAGTGGAGAGAAA-39 and 59-ATGGC-
GACAGGGAAGGAGAA-39 for mouse TSHb, 59-CAGCCT-
GATGTTTGGTACCTCGGA-39. Signals were quantified using
ImageJ software.
Statistical analysis
All the results are expressed as mean6SEM. The statistical
significance of the differences between the groups was examined
using Student’s t-test, Mann-Whitney U test, or repeated-measures
analysis of variance (ANOVA), as appropriate, and the STAT-
VIEW program. When a significant F ratio was obtained, we
conducted post-hoc analysis by using Fisher’s protected least-
significant difference (PLSD) test. P,0.05 was considered to be
significant.
Supporting Information
Video S1 Real-time motion of EGFP-TSHb granules close to
the plasma membrane of the pituitary cells was monitored at 5 s
intervals by TIRF microscopy. Scale bar, 20 mm.
Found at: doi:10.1371/journal.pone.0011755.s001 (0.06 MB AVI)
Video S2 Real-time motion of EGFP-TSHb granules close to
the plasma membrane of the SIRT1-overexpressing pituitary cells
was monitored at 5 s intervals by TIRF microscopy. Scale bar,
20 mm.
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Video S3 Real-time motion of EGFP-TSHb granules close to
the plasma membrane of SIRT1-RNAi pituitary cells was
monitored at 5 s intervals by TIRF microscopy. Scale bar, 20 mm.
Found at: doi:10.1371/journal.pone.0011755.s003 (0.06 MB AVI)
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